Literature DB >> 9119227

An HMG I/Y-containing repressor complex and supercoiled DNA topology are critical for long-range enhancer-dependent transcription in vitro.

R Bagga1, B M Emerson.   

Abstract

The 3' enhancer of the T cell receptor alpha-chain (TCR alpha) gene directs the tissue- and stage-specific expression and V(D)J recombination of this gene locus. Using an in vitro system that reproduces TCR alpha enhancer activity efficiently, we show that long-range promoter-enhancer regulation requires a T cell-specific repressor complex and is sensitive to DNA topology. In this system, the enhancer functions to derepress the promoter on supercoiled, but not relaxed, templates. We find that the TCR alpha promoter is inactivated by a repressor complex that contains the architectural protein HMG I/Y. In the absence of this repressor complex, expression of the TCR alpha gene is completely independent of the 3' enhancer and DNA topology. The interaction of the T cell-restricted protein LEF-1 with the TCR alpha enhancer is required for promoter derepression. In this system, the TCR alpha enhancer increases the number of active promoters rather than the rate of transcription. Thus, long-range enhancers function in a distinct manner from promoters and provide the regulatory link between repressors, DNA topology, and gene activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119227     DOI: 10.1101/gad.11.5.629

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  14 in total

1.  Variegated expression of the endogenous immunoglobulin heavy-chain gene in the absence of the intronic locus control region.

Authors:  D Ronai; M Berru; M J Shulman
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 2.  Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins.

Authors:  M Bustin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

3.  HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology.

Authors:  R Bagga; S Michalowski; R Sabnis; J D Griffith; B M Emerson
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

4.  The nucleosome remodeling complex, Snf/Swi, is required for the maintenance of transcription in vivo and is partially redundant with the histone acetyltransferase, Gcn5.

Authors:  P Sudarsanam; Y Cao; L Wu; B C Laurent; F Winston
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

5.  The high-mobility group A-type protein CarD of the bacterium Myxococcus xanthus as a transcription factor for several distinct vegetative genes.

Authors:  Marisa Galbis-Martínez; Marta Fontes; Francisco J Murillo
Journal:  Genetics       Date:  2004-08       Impact factor: 4.562

6.  Rationally designed insulator-like elements can block enhancer action in vitro.

Authors:  Vladimir A Bondarenko; Yong I Jiang; Vasily M Studitsky
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

Review 7.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

8.  Functional analysis of DNA bending and unwinding by the high mobility group domain of LEF-1.

Authors:  K Giese; J Pagel; R Grosschedl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

9.  Nuclear matrix attachment regions antagonize methylation-dependent repression of long-range enhancer-promoter interactions.

Authors:  W C Forrester; L A Fernández; R Grosschedl
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

10.  Specific binding of high-mobility-group I (HMGI) protein and histone H1 to the upstream AT-rich region of the murine beta interferon promoter: HMGI protein acts as a potential antirepressor of the promoter.

Authors:  E Bonnefoy; M T Bandu; J Doly
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.